Register Login

Chromogenic Vs. Clot-based FVIII Assays

The Precision BioLogic Inc. and the Affinity Biologicals, Inc. research team presented a poster comparing chromogenic versus clot-based factor VIII assays measuring pegylated factor VIII therapeutic concentrate at the July 17–21, 2021 meeting of the International Society on Thrombosis and Haemostasis. The poster is now available for your download: Tara Quinton, John Fraser, Karen M. Black, Ali Sadeghi-Khomami. Comparison of a Chromogenic vs. APTT-based Factor VIII Activity Assay in the Recovery of a Pegylated Factor VIII Replacement Therapy in Plasma Samples.


Comments (0)
Bleeding Disorders

No comments here.

Leave a Reply